IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

IDXX

$523.46

Updated: 22/09/2026, 19:27:43

Market Cap
$41.29B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Stock valuation chart
One-year closing share-price history for IDXX
Company Profile

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

USD
NASDAQ
CEO: Michael Erickson
Employees: 11,000
https://www.idexx.com
Asset Summaries
Latest generated summaries for IDXX

No summaries found.

Detailed business
The latest official filing is available; structured extraction is pending.
IDXX-10-k-fy2025.html2.8 MBtext/htmlENFiled 20/02/2026Period ended 31/12/2025

The original document can be viewed now. Detailed facts and exposure relationships will appear after the separate extraction job completes.

Full company information
Latest profile, trading, valuation, and identifier data stored for IDXX.
Share price
$523.46
Market cap
$41.29B
Exchange
NASDAQ
Currency
USD
CEO
Michael Erickson
Employees
11,000
IPO date
21/06/1991
Beta
1.538
Last dividend
$0.00
Day range
$511.73 – $523.52
52-week range
$500.61 – $769.98
1-day performance
1.58%
1-year performance
4.56%
Current drawdown (1Y)
-32.02%
CIK
0000874716
CUSIP
45168D104
ISIN
US45168D1046
Created
07/12/2025, 04:40:35
Last update
22/09/2026, 19:27:43

Track IDEXX Laboratories, Inc. with an AI analyst

See which prediction-market events move IDXX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to IDXX from your Railway `news_articles` table.

Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock

Zacks Investment Research • STOCK • 11/06/2026, 12:52:04

Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock

Zacks Investment Research • STOCK • 09/06/2026, 12:46:12

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

MarketBeat • STOCK • 30/05/2026, 09:02:41

IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript

Seeking Alpha • STOCK • 27/05/2026, 15:27:05

IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day

Business Wire • STOCK • 14/05/2026, 18:34:00

IDEXX Laboratories (NASDAQ: IDXX) Reports Strong Quarterly Results, Exceeding Expectations

Market Data • Market Data • 05/05/2026, 21:01:12

IDEXX Laboratories, Inc. (IDXX) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 05/05/2026, 16:11:13

IDEXX Stock Up on Q1 Earnings & Revenue Beat, Margins Rise, '26 View Up

Zacks Investment Research • STOCK • 05/05/2026, 13:31:21

Idexx Laboratories (IDXX) Q1 Earnings and Revenues Surpass Estimates

Zacks Investment Research • STOCK • 05/05/2026, 10:45:30

IDEXX Laboratories Announces First Quarter Results

Business Wire • STOCK • 05/05/2026, 08:30:00

Here's How IDEXX Laboratories Is Placed Ahead of Q1 Earnings

Zacks Investment Research • STOCK • 01/05/2026, 12:11:20

IDEXX Laboratories (NASDAQ: IDXX) Stock Analysis: Neutral Rating Amid Valuation Concerns and Growth Drivers

Market Data • Market Data • 28/04/2026, 16:11:01